Sinopharm Group CoSHTDY -0.30%73 Dividend Yield % is 5.03% as of Jun. 26, 2026, which is 43% above its 10-year median of 3.52. GuruFocus rates SHTDY with a GF Score™ of 73/100 and a GF Value™ of $13.44 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 69 Medical Distribution companies, Sinopharm Group Co ranks better than 78.26% on this metric.
As of today (2026-06-26), the Trailing Annual Dividend Yield of Sinopharm Group Co is 5.03%.
Good Sign:
Sinopharm Group Co Ltd stock Dividend Yield % is close to 3-year high.
The historical rank and industry rank for Sinopharm Group Co's Dividend Yield % or its related term are showing as below:
SHTDY'
s Dividend Yield % Range Over the Past 10 Years
Min: 0.9 Med: 3.52 Max: 5.85
Current: 5.03
During the past 13 years, the highest Dividend Yield of Sinopharm Group Co was 5.85%. The lowest was 0.90%. And the median was 3.52%.
SHTDY's Dividend Yield % is ranked better than 78.26% of 69
companies
in the Medical Distribution industry
Industry Median: 2.89
vs SHTDY: 5.03
During the past 12 months, Sinopharm Group Co's average Dividends Per Share Growth Rate was -21.50% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was -3.60% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 1.90% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 7.80% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Sinopharm Group Co was 198.40% per year. The lowest was -3.60% per year. And the median was 12.40% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Sinopharm Group Co (OTCPK:SHTDY) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Sinopharm Group Co Dividend Yield % Historical Data
* Premium members only.
The historical data trend for Sinopharm Group Co's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHTDY vs MCK, COR, CAH: Dividend Yield % Comparison
For the Medical Distribution subindustry, Sinopharm Group Co's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sinopharm Group Co Dividend Yield % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Sinopharm Group Co's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Sinopharm Group Co's Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Sinopharm Group Co Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
USD 0.509503
2026-06-24
2026-06-24
2026-09-08
Cash Dividend
annually
USD:USD 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Sinopharm Group Co's Trailing Annual Dividend Yield (%) for Today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sinopharm Group Co (SHTDY) has a Dividend Yield % of 5.03% as of Jun. 26, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Sinopharm Group Co and its competitors. This is 43% above median its historical median of 3.52. Over the past decade, Sinopharm Group Co's Dividend Yield % has ranged from 0.90 to 5.85. According to the industry distribution chart, Sinopharm Group Co ranks #15 out of 69 companies in the Medical Distribution industry, placing it in the top 21.7%.
Is Sinopharm Group Co's Dividend Yield % too high?
Sinopharm Group Co's current Dividend Yield % of 5.03% is 43% above median its 10-year median of 3.52. Over the past 10 years, this metric has ranged from a low of 0.90 to a high of 5.85. The Medical Distribution industry median Dividend Yield % is 2.89. Sinopharm Group Co's value of 5.03% is 74% above this industry median. Based on the distribution chart, Sinopharm Group Co ranks #15 out of 69 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Sinopharm Group Co has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sinopharm Group Co's Dividend Yield % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Sinopharm Group Co ranks #15 out of 69 companies for Dividend Yield %. This places Sinopharm Group Co in the top 22% of its industry — outperforming the majority of peers. The industry median Dividend Yield % is 2.89. Sinopharm Group Co's value of 5.03% is 74% above this benchmark. Historically, Sinopharm Group Co's own Dividend Yield % has ranged from 0.90 to 5.85 over the past decade. While the company's 10-year median is 3.52 vs. the industry median of 2.89, Sinopharm Group Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Medical Distribution company?
The median Dividend Yield % among Medical Distribution companies is 2.89, based on 69 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sinopharm Group Co's current Dividend Yield % of 5.03% is 74% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Sinopharm Group Co and its competitors. For the Medical Distribution industry, the median Dividend Yield % is 2.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sinopharm Group Co's current Dividend Yield % is 5.03%, which is 43% above median its own 10-year median of 3.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sinopharm Group Co stock overvalued right now?
Based on GuruFocus' analysis, Sinopharm Group Co (SHTDY) is currently considered Modestly Undervalued. The stock's GF Value™ is $13.44, compared to a current price of $10.14 — trading 24.6% below its estimated fair value. The current Dividend Yield % is 5.03%, which is 43% above median its 10-year median of 3.52 and 74% above the Medical Distribution industry median of 2.89. Sinopharm Group Co's overall GF Score™ is 73/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Sinopharm Group Co (SHTDY), the current Dividend Yield % is 5.03% as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sinopharm Group Co (SHTDY) Overvalued in 2026?
Based on GuruFocus' analysis, Sinopharm Group Co stock appears to be undervalued.
The current stock price of $10.14 is trading 24.6% below its estimated GF Value™ of $13.44.
GuruFocus considers Sinopharm Group Co to be Modestly Undervalued.
Key valuation signals for SHTDY:
Dividend Yield %: 5.03% (43% above median its 10-year median of 3.52)
GF Value™: $13.44 vs. price of $10.14 (24.6% below fair value)
Industry Position: 74% above the Medical Distribution median (#15 of 69)
No single metric tells the full story. See the SHTDY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Founded in 2003, Sinopharm is the largest wholesaler and retailer of drugs and medical devices in China and listed on the Hong Kong Stock Exchange in 2009. It is a core subsidiary of China National Pharmaceutical Group. Sinopharm's largest operating segment is pharmaceutical distribution, making up over 70% of its total revenue by the end of 2024. In 2018, Sinopharm acquired the largest Chinese medical device distributor, China National Scientific Instruments and Materials. Now, medical device distribution accounts for over 20% of Sinopharm's total revenue. Sinopharm's downstream customers range from hospitals and other health services institutions to end-customers.
73GF Score
Get the complete analysis for SHTDY
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHTDY has been successfully added to your 
